Biotechnology
Company Overview of River Vision Development Corp.
Company Overview
River Vision Development Corp. develops RV001, a protein therapy for the treatment of Graves’ Orbitopathy (GO). The company was founded in 2011 and is based in New York, New York.
One Rockefeller Plaza
Suite 1204
New York, NY 10020
United States
Founded in 2011
Phone:
212-582-8400
Key Executives for River Vision Development Corp.
Compensation as of Fiscal Year 2012.
Similar Private Companies By Industry
| Company Name | Region |
| Savage Laboratories, Inc. | United States |
| Sabinsa Corporation | United States |
| HEPI Pharmaceuticals Inc. | United States |
| Puracap Pharmaceutical LLC | United States |
| Jenner Technologies Inc | United States |
Recent Private Companies Transactions
| Type Date |
Target |
|
Private Placement
November 20, 2012 |
-- |
Most Searched Private Companies
| Company Name | Geographic Region |
| Bertelsmann AG | Europe |
| Lawyers Committee for Civil Rights Under Law | United States |
| NYC2012, Inc. | United States |
| Rush University | United States |
| Citizens Budget Commission | United States |
Post a JobJobs
- Boston, MA | PwCPosted: Aug 28
- Buffalo, NY | Major International BankPosted: Jun 17
- Greenfield, IN |Posted: May 30
- Illinois | Miller AgPosted: Jun 14
Sponsored Financial Commentaries
Sponsored Links
Report Data Issue
To contact River Vision Development Corp., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.
Please enter your information in the following field(s):
Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
